You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (178)

Journals (0)

1-10 of 178 results for FDA interactions

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Planning for Effective Interaction with FDA

Retricted access

Research article

First published 2004-12

Planning for Effective Interaction with FDA

Elizabeth A. Spurgin

Diabetes Technology & Therapeutics

Select article: Compiling Information about Drug Interactions for the FDA

Retricted access

Research article

First published 1972-1

Compiling Information about Drug Interactions for the FDA

Albert F. Esch

Therapeutic Innovation & Regulatory Science

Select article: Adverse reactions of immune checkpoint inhibitors combined with angiogenesis inhibitors: A pharmacovigilance analysis of drug–drug interactions

Open access

Research article

First published 2024

Adverse reactions of immune checkpoint inhibitors combined with angiogenesis inhibitors: A pharmacovigilance analysis of drug–drug interactions

Xiayang Ren, Lei Deng, Xin Dong [...]

International Journal of Immunopathology and Pharmacology

Select article: Balancing Acts: An Analysis of Food and Drug Administration Letters about Direct-to-Consumer Advertising Violations

Retricted access

Research article

First published 2003-9

Balancing Acts: An Analysis of Food and Drug Administration Letters about Direct-to-Consumer Advertising Violations

Kim Bartel Sheehan

Journal of Public Policy & Marketing

Select article: Preparing for FDA Advisory Committee Presentations: Perspective of an Advisory Committee Member *

Retricted access

Other

First published 2000-1

Preparing for FDA Advisory Committee Presentations: Perspective of an Advisory Committee Member *

Richard L. Schilsky

Therapeutic Innovation & Regulatory Science

Select article: The Interactive IND/NDA

Retricted access

Research article

First published 1996-7

The Interactive IND/NDA

Loren Miller, Jill Buckley, Richard Crawley

Therapeutic Innovation & Regulatory Science

Select article: Adverse Drug Reactions and the Food and Drug Administration

Retricted access

Research article

First published 1989-8

Adverse Drug Reactions and the Food and Drug Administration

Kay C. Pearson, Dianne L. Kennedy

Journal of Pharmacy Practice

Select article: How FDA Advisory Committee Members Prepare and What Influences Them

Retricted access

Research article

First published 2013-1

How FDA Advisory Committee Members Prepare and What Influences Them

Todd D. McIntyre, Mimi Pappas, James J. DiBiasi

Therapeutic Innovation & Regulatory Science

Select article: A reflection on paradigmatic tensions within the FDA advisory committee for MDMA-assisted therapy

Open access

Research article

First published 2025-4

A reflection on paradigmatic tensions within the FDA advisory committee for MDMA-assisted therapy

Leor Roseman

Journal of Psychopharmacology

Select article: Regulatory Decision Strategy for Entry of a Novel Biologic Therapeutic with a Clinically Unmonitorable Toxicity into Clinical Trials: Pre-IND Meetings and a Case Example

Free access

Research article

First published 1999-01

Regulatory Decision Strategy for Entry of a Novel Biologic Therapeutic with a Clinically Unmonitorable Toxicity into Clinical Trials: Pre-IND Meetings and a Case Example

Lauren E. Black, Alison M. Bendele, Ray A. Bendele [...]

Toxicologic Pathology

1
2
3
•••
18
10 / page

Article type

Publication date

Subjects

Access